Charles Deignan - Jan 8, 2025 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLSD	Employee Stock Option (right to buy)	Award	$0	+200K		$0.00	200K	Jan 8, 2025	Common Stock	200K	$0.97	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One-fourth of the shares underlying this option vest on January 8, 2026 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.